期刊
BIOACTIVE MATERIALS
卷 22, 期 -, 页码 466-481出版社
KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2022.10.013
关键词
Restenosis; Vein graft; Extravascular stent; NC-Gelatin hydrogel; EndMT
In this study, a drug-loaded nanocellulose-gelatin hydrogel extravascular stent was developed to prevent restenosis of vein grafts. The stent showed excellent biocompatibility and the ability to resist restenosis by activating autophagy.
Vein grafts are widely used for coronary artery bypass grafting and hemodialysis access, but restenosis remains the Achilles' heel of these treatments. An extravascular stent is one wrapped around the vein graft and provides mechanical strength; it can buffer high arterial pressure and secondary vascular dilation of the vein to prevent restenosis. In this study, we developed a novel Nanocellulose-gelatin hydrogel, loaded with the drug Astraga-loside IV (AS-IV) as an extravascular scaffold to investigate its ability to reduce restenosis. We found that the excellent physical and chemical properties of the drug AS-IV loaded Nanocellulose-gelatin hydrogel external stent limit graft vein expansion and make the stent biocompatible. We also found it can prevent restenosis by resisting endothelial-to-mesenchymal transition (EndMT) in vitro. It does so by activating autophagy, and AS-IV can enhance this effect both in vivo and in vitro. This study has added to existing research on the mechanism of extravascular stents in preventing restenosis of grafted veins. Furthermore, we have developed a novel extra -vascular stent for the prevention and treatment of restenosis. This will help optimize the clinical treatment plan of external stents and improve the prognosis in patients with vein grafts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据